Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Norman, Sharpe"'
Autor:
Malcolm West, Adrienne Kirby, Ralph A. Stewart, Stefan Blankenberg, David Sullivan, Harvey D. White, David Hunt, Ian Marschner, Edward Janus, Leonard Kritharides, Gerald F. Watts, John Simes, Andrew M. Tonkin, Neil Anderson, Ralph Stewart, Harvey White, Paul Nestel, Paul Glasziou, Marian Gandy, Jeannie Joughin, Jennifer Seabrook, Jenny Stephenson, Alison Clague, Stephen MacMahon, Philip Aylward, Malcolm Whiting, John McNeil, Andrew Tonkin, Craig Anderson, Jenny Baker, Elizabeth Barnes, Wendy Hague, Anthony Keech, Li‐Ping Li, Sarah Mulray, Helen Pater, Kristy Robledo, R. John Simes, Paul Magnus, John Shaw, Rory Collins, Andrew Thomson, Phillip Harris, Norman Sharpe, Paul Meier, Philip Barter, John Watson, Lawrence Beilin, Graeme Hankey, Michael Hobbs, Peter Thompson, Gerald Watts, David Colquhoun
Publikováno v:
Journal of the American Heart Association. 11(5)
Background Elevated plasma cystatin C levels reflect reduced renal function and increased cardiovascular risk. Less is known about whether the increased risk persists long‐term or is independent of renal function and other important biomarkers. Met
Autor:
Norman Sharpe
Publikováno v:
Heart, lungcirculation. 24(4)
During the 1960s, the need for a Heart Foundation in New Zealand became increasingly obvious as coronary heart disease mortality rates continued to rise to very high levels; the National Heart Foundation was established in 1968 (see Box 1). The princ
Publikováno v:
European Journal of Echocardiography. 6:134-143
Aims Wall motion score index (WMSI) is an important prognostic indicator in heart failure (HF) patients but requires endocardial visualisation. This study evaluated the role tissue harmonic imaging (THI) and contrast opacification (LVO) for improving
Autor:
Ian Ford, Willem J. Remme, Wilson S. Colucci, John J.V. McMurray, D. Norman Sharpe, Jose Lopez-Sendon, Henry J. Dargie, Lars Køber, Michele Robertson
Publikováno v:
Journal of the American College of Cardiology. 45(4):525-530
OBJECTIVES Whether beta-blockers reduce atrial arrhythmias and, when added to an angiotensin-converting enzyme (ACE) inhibitor, ventricular arrhythmia is unknown. BACKGROUND Ventricular and atrial arrhythmias are common after acute myocardial infarct
Autor:
Norman Sharpe
Publikováno v:
Current Heart Failure Reports. 1:9-13
Clinical research during the past several decades has shown the importance of cardiac remodeling as a basic mechanism in the progression of heart failure. Changes in cardiac remodeling have high concordance with long-term clinical outcomes. Cardiac r
Autor:
José López-Sendón, Robert N. Doughty, Gillian A. Whalley, H. Walsh, Greg D. Gamble, Norman Sharpe
Publikováno v:
Circulation. 109:201-206
Background— The CAPRICORN trial has shown that carvedilol improved outcome in patients with left ventricular dysfunction after acute myocardial infarction treated with ACE inhibitors. The aim of this substudy was to determine the effects of carvedi
Autor:
Norman Sharpe, A. Pearl, Stephanie A. Muncaster, Helen J. Walsh, Robert N. Doughty, Greg D. Gamble, Susan P. Wright
Publikováno v:
Family Practice. 20:642-645
Recent studies have investigated specific strategies for heart failure management. None has involved collaboration between primary and secondary care. Potential gains for patients may result from collaborative strategies.To assess the effect of an in
Autor:
Jean L. Rouleau, Matthias Straub, Marc A. Pfeffer, Jay N. Cohn, Curtis Wiltse, Norman Sharpe, Karl Swedberg, Theressa J. Wright
Publikováno v:
European Journal of Heart Failure. 5:659-667
Background: The association between sympathetic activation and mortality in chronic heart failure and the favorable effect of beta blocking drugs has raised the possibility of therapeutic efficacy for central sympathetic inhibition with sustained-rel